Concepedia

Publication | Open Access

Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial

DOIFull Paper Access

295

Citations

15

References

2016

Year

Robert H.I. Andtbacka, Merrick Ross, Igor Puzanov, Mohammed Milhem, Frances A. Collichio, Keith A. Delman, Thomas Amatruda, Jonathan S. Zager, Lee D. Cranmer, Eddy C. Hsueh,
Annals of Surgical Oncology

Abstract

Responses in uninjected lesions provide validation of T-VEC-induced systemic immunotherapeutic effects against melanoma. PPR did not negatively impact the clinical effectiveness of T-VEC.

References

YearCitations

Page 1